Evidence map›Paper›PMID 26025090›Full record

ArticleBMC genomics2015

Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airways.

Jose Antonio Méndez, Jesús Mateos, Alejandro Beceiro, María Lopez, María Tomás, Margarita Poza, Germán Bou

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Designing Multi-Antigen Vaccines AgainstFrontiers in immunology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Analysis of Differentially Expressed Proteins inBioMed research international · 2017
    Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jose Antonio MéndezMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. jose.antonio.mendez.arredondo@sergas.es.
Jesús MateosGrupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia, A Coruña, Spain. Jesus.Mateos.Martin@sergas.es.
Alejandro BeceiroMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. Alejandro.Beceiro.Casas@sergas.es.
María LopezMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. malopedi@gmail.com.
María TomásMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. MA.del.Mar.Tomas.Carmona@sergas.es.
Margarita PozaMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. Margarita.Poza.Dominguez@sergas.es.
Germán BouMicrobiology Division, INIBIC-Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain. German.Bou.Arevalo@sergas.es.
Complexo Hospitalario Universitario A Coruña · ESInstituto de Investigación Biomédica de A Coruña · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcinetobacter baumannii is a major health problem. The most common infection caused by A. baumannii is hospital acquired pneumonia, and the associated mortality rate is approximately 50%. Neither in vivo nor ex vivo expression profiling has been performed at the proteomic or transcriptomic level for pneumonia caused by A. baumannii. In this study, we characterized the proteome of A. baumannii under conditions that simulate those found in the airways, to gain some insight into how A. baumannii adapts to the host and to improve knowledge about the pathogenesis and virulence of this bacterium. A clinical strain of A. baumannii was grown under different conditions: in the presence of bronchoalveolar lavage fluid from infected rats, of RAW 264.7 cells to simulate conditions in the respiratory tract and in control conditions. We used iTRAQ labelling and LC-MALDI-TOF/TOF to investigate how A. baumannii responds on exposure to macrophages/BALF.

results179 proteins showed differential expression. In both models, proteins involved in the following processes were over-expressed: (i) pathogenesis and virulence (OmpA, YjjK); (ii) cell wall/membrane/envelope biogenesis (MurC); (iii) energy production and conversion (acetyl-CoA hydrolase); and (iv) translation (50S ribosomal protein L9). Proteins involved in the following were under-expressed: (i) lipid metabolism (short-chain dehydrogenase); (ii) amino acid metabolism and transport (aspartate aminotransferase); (iii) unknown function (DNA-binding protein); and (iv) inorganic ion transport and metabolism (hydroperoxidase).

conclusionsWe observed alterations in cell wall synthesis and identified 2 upregulated virulence-associated proteins with >15 peptides/protein in both ex vivo models (OmpA and YjjK), suggesting that these proteins are fundamental for pathogenesis and virulence in the airways. This study is the first comprehensive overview of the ex vivo proteome of A. baumannii and is an important step towards identification of diagnostic biomarkers, novel drug targets and potential vaccine candidates in the fight against pneumonia caused by A. baumannii.

Indexed as

ProteomicsAcinetobacter baumanniiAnimalsAspartate AminotransferasesBacterial ProteinsBronchoalveolar Lavage FluidCell LineCell WallDNA-Binding ProteinsEnergy MetabolismHost-Pathogen InteractionsLipid MetabolismLungMaleMiceModels, BiologicalAspartate AminotransferasesBacterial ProteinsDNA-Binding ProteinsProteomeVirulence Factors

Identifiers

PMID26025090
PMCPMC4449591
OpenAlexW1844742360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.